WA-MARY-KAY
2.6.2022 22:55:07 CEST | Business Wire | Press release
Calling all models—your virtual runway awaits! Step & Repeat, the first ever style and fashion competition launched on TikTok, returns for season two on June 7. Last year, Glamhive and Mary Kay Global Design Studio unveiled the fashion reality contest that reached millions of users worldwide. Now, the four-week style challenge is back and promises to be the fashion extravaganza we’ve all been waiting for.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220602005868/en/
Celebrity Stylist Zadrian Smith (clients include: Ariana DeBose, Naama Preis, Naomi Scott) hosts Step & Repeat with three judges and industry favorites: celebrity stylist Tara Swennen (clients include: Kristen Stewart, Matthew McConaughey), celebrity stylist Nicole Chavez (clients include: Kristen Bell, Jessica Simpson), and celebrity hairstylist Larry Sims (clients include: Victoria Beckham, Queen Latifah).
Each week, host Zadrian Smith will announce a theme-based challenge for TikTok users to showcase their creativity through wardrobe, makeup, and hair. The show’s celebrity judges will duet the best looks from around the world and cast their votes for winners in each category. Participants are asked to incorporate the show’s custom sound, “Step & Repeat,” and hashtags, #stepandrepeat, #glamhive, and #marykay to enter their video into the competition. For each challenge there will be three winners, hand-picked by the judges, who will receive a cash prize plus an hour one-on-one meeting with an industry mentor.
At the end of the four weeks, Step & Repeat will announce one overall winner for each category, crowning them the very best in wardrobe, makeup, and hair based on entries from all over the world. TikTok is the place for anyone with talent and a creative voice to share their gift on a global scale. Step & Repeat is the platform that gives you the opportunity to be seen and celebrated.
Zadrian Smith, Celebrity Stylist (Host)
“As my career has progressed as a Global Fashion Director and Journalist, I’ve wanted to prioritize working to create a more equitable fashion industry. It’s not always easy or comfortable work, but any opportunity that I can provide to help other people interested in the industry with a step up - that’s a conversation that I want to be a part of.”
Tara Swennen, Celebrity Stylist (Judge)
“There are so many people with incredible creative talent and Step & Repeat gives them a place to shine. I'm very excited to see the looks that people from all over the world will be debuting on our social media runway!”
Nicole Chavez, Celebrity Stylist (Judge)
“Season One of ‘Step & Repeat’ absolutely inspired me. I was excited every week to see what the contestants created and blown away by the range of talent. I can't wait to see the results of our challenges in Season Two!”
Larry Sims, Celebrity Hairstylist (Judge)
“It takes courage, confidence, & creativity to show the world why you're an amazing artist. I’m excited to see the contestants bring it!”
Stephanie Sprangers, Founder and CEO of Glamhive
“Our vision for ‘Step & Repeat’ was to create a fast-paced style competition that encompassed creativity, inclusivity, connections, and recognition, and Season One delivered in spades. Now, for the second time, the industry's best are coming together to welcome and encourage style talent from around the world. We're so excited to see what happens in Season Two.”
Step & Repeat Mentors:
- Claire Sulmers, CEO & Founder of Fashion Bomb Daily
- Adam Drawas, Owner, Walker Drawas PR
- Quentin Thrash, Bespoke Designer & Celebrity Barber
- Brian Underwood, Fashion Director, Women’s Health
- Mandi Line, Costume Designer (The Bold Type, Pretty Little Liars, Shameless)
- Pandora Amoratis, Style Director, US Daily Mail
- Sheridan Ward, Celebrity Hairstylist
- Shatora Adrell, Fashion Designer and Stylist
- Carrie Colbert, Founding & General Partner, Curate Capital
- Quinn Murphy, Celebrity Makeup Artist
- Alexis Bennett, Editor, Vogue
- Gilda Koral Flora, Founder, Koral Communications
- Christian Wood, Celebrity Hairstylist
For more information, visit https://www.glamhive.com/tiktok
About Glamhive: Glamhive was founded by entrepreneur Stephanie Sprangers in 2017 with the vision to democratize personal styling and the premise that the confidence that comes with glamour should not be exclusive to the rich and famous. The online styling experience offers anyone with a WiFi connection access to stylists who will provide them with the support they need to be the best version of themselves. For stylists, it is a seamless end-to-end platform to help them grow their network and their business, 100% virtually.
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty company in 1963 with one goal: enriching women’s lives. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. As an entrepreneurship development company, Mary Kay is committed to empowering women on their journey through education, mentorship, advocacy, networking, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in enriching lives today for a sustainable tomorrow, partnering with organizations from around the world focusing on promoting business excellence, supporting cancer research, advancing gender equality, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Learn more at marykayglobal.com , find us on Facebook , Instagram , and LinkedIn , or follow us on Twitter .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220602005868/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)29.6.2026 09:19:00 CEST | Press release
Phase 1 study demonstrated pharmacokinetic (PK) equivalence between SB27 and Keytruda; Phase 3 study demonstrated equivalent objective response rate (ORR) at Week 24Phase 1 and Phase 3 studies expected to be completed within 2026 Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), have met their primary endpoints. “We are excited to announce preliminary results from the Phase 1 and Phase 3 studies for SB27, our pembrolizumab biosimilar candidate. These topline positive results reinforce our scientific expertise and leadership in biosimilar development,” said Donghoon Shin, Executive Vice President and Head of Clinical Sciences Division at Samsung Bioepis. “We are on track to complete both Phase 1 and Phase 3 studies within this year. Leveraging our robust quality management system, we remain committed to advancing our biosimilar portfolio to broaden access to life-saving biologic medicines for patie
IQM Named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment29.6.2026 09:00:00 CEST | Press release
IQM today announced it has been named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629748732/en/ IQM named a major player in the IDC MarketScape IQM believes this recognition comes as institutions worldwide move quantum computing out of shared cloud access and into infrastructure they own and operate themselves. IQM calls this Production Quantum: full-stack, open-architecture superconducting systems deployed on premises, inside customers' own data centers and HPC environments, where organizations own the hardware, build internal expertise, and run quantum processors alongside their existing classical infrastructure. According to the IDC MarketScape, "For institutions building long-term quantum programs, this means the workflows and intellectual property developed on IQM hardware remain portable." The report further advises: "Consi
Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations29.6.2026 09:00:00 CEST | Press release
Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time with fewer daily doses compared with immediate-release levodopa/carbidopa More than one million people are living with Parkinson’s disease in the European Union, and over 80% experience motor fluctuations during the course of their disease, highlighting the need for additional treatment options Hopledo® contains a unique formulation combining immediate-release granules and extended-release pellets, providing both a rapid onset of action and a longer duration of effect, sustaining the levodopa therapeutic effect for a longer period of time If approved, Zambon expects to make Hopledo® progressively available to patients with Parkinson’s disease across Europe starting October 2026 Zambon today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European M
Enhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors29.6.2026 08:30:00 CEST | Press release
Approval based on three phase 2 trials of Daiichi Sankyo and AstraZeneca’s Enhertu that demonstrated clinically meaningful responses across a broad range of tumors Enhertu now approved for six indications in the EU Enhertu® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from subgroups of patients with HER2 positive (IHC 3+) tumors across thr
Beerenberg Prevails in Patent Case Against Aspen Aerogels29.6.2026 07:00:00 CEST | Press release
The ruling confirms that Beerenberg did not infringe Aspen Aerogels’ patents. The Korean Patent Court has invalidated three of Aspen Aerogels’ patents related to improved hydrophobic aerogel material. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260628192007/en/ Beerenberg delivers high-end insulation solutions built for performance, reliability, and long-term value. (Photo: Beerenberg) The ruling confirms the conclusion of the Intellectual Property Trial and Appeal Board (IPTAB) that the patents did not meet the necessary requirements for patentability. Beerenberg, which specializes in high-end insulation products, welcomes the court’s decision. “We are pleased that the case has now been concluded and that any uncertainty regarding the infringement claims has been removed,” says CEO Arild Apelthun. About Beerenberg Beerenberg has delivered cost-efficient solutions to a wide range of industrial enterprises for 49 years. Th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom